Preparation and therapeutic applications of (2S,3R)- N-2-((3-pyridinyl)methyl)-1azabicyclo[2.2.2]oct-3-yl)-3,5-difluorobenzamide

Details for Australian Patent Application No. 2012238322 (hide)

Owner Targacept, Inc.

Inventors Bencherif, Merouane; Fedorov, Nikolai; Hauser, Terry; Jordan, Kristen; Letchworth, Sharon Rae; Mazurov, Anatoly; Munoz, Julio A.; Speake, Jason; Yohannes, Daniel

Agent FB Rice

Pub. Number AU-A-2012238322

Parent 2010206638

Filing date 11 October 2012

Wipo publication date 1 November 2012

International Classifications

C07D 453/02 Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids

A61K 31/439 - the ring forming part of a bridged ring system, e.g. quinuclidine

A61P 3/00 Drugs for disorders of the metabolism

A61P 25/02 Drugs for disorders of the nervous system

A61P 25/04 Drugs for disorders of the nervous system

A61P 25/06 Drugs for disorders of the nervous system

A61P 25/28 Drugs for disorders of the nervous system

A61P 29/00 Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

Event Publications

25 October 2012 Complete Application Filed

1 November 2012 Application Open to Public Inspection

  Published as AU-A-2012238322

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2012238323-Oriented Contact Lens with Brightly Colored Sclera

2012238321-Gene expression signatures in blood leukocytes permit differential diagnosis of acute infections